Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2010
A selective peroxisome proliferator-activated receptor alpha agonist, CP-900691, improves plasma lipids, lipoproteins, and glycemic control in diabetic monkeysJanice D Wagner, Melanie K Shadoan, Li Zhang, et al.
Journal of Lipid Research|October 11, 2008
The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and bindingOmar L Francone, Meihua Tu, Lori J Royer, et al.
The American Journal of Pathology|August 29, 2006
A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosisIngrid Pruimboom-Brees, Mehrdad Haghpassand, Lori Royer, et al.
Journal of Lipid Research|July 21, 2011
Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levelsOmar L Francone, Brian Y Ishida, Margarita de la Llera-Moya, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2000
High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1J McNeish, R J Aiello, D Guyot, et al.
Journal of Lipid Research|December 8, 2009
Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infectionRonald W Clark, David Cunningham, Yang Cong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysisGabriel Birrane, Anne P Beigneux, Brian Dwyer, et al.
Molecular Pharmacology|October 31, 2008
Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivoChristopher D Kane, Kimberly A Stevens, James E Fischer, et al.
Pageof 6